Product Certification&
    Enterprise Certification

  • Ms.zhang
    Tel: +862759707018

  • Ms.kate
    Tel: +86-16607120890

  • Mobile:+8613627115097
  • Tel:+862759707018
  • Fax:
  • URL:http://www.senwayer.com
  • Province/state:Hubei
  • City:Wuhan
  • Street:武昌区松竹路与烟霞路交叉处
  • MaxCard:
Home > Products >  USA warehouse High quatity Raloxifene powder cas 84449-90-1

USA warehouse High quatity Raloxifene powder cas 84449-90-1 CAS NO.84449-90-1

  • FOB Price: USD: 1.00-1.50 /Gram Get Latest Price
  • Min.Order: 100 Gram
  • Payment Terms: L/C,D/A,D/P,T/T,Other
  • Available Specifications:

    99%(100-500)Gram99%(500-1000)Gram

  • Product Details

Keywords

  • Raloxifene
  • cas 84449-90-1
  • Raloxifene powder

Quick Details

  • ProName: USA warehouse High quatity Raloxifene ...
  • CasNo: 84449-90-1
  • Molecular Formula: C28H27NO4S
  • Appearance: powder
  • Application: cosmetic
  • DeliveryTime: 15days
  • PackAge: 1KG/Bag 25KG/drum
  • Port: Shanghai
  • ProductionCapacity: 1000 Kilogram/Month
  • Purity: 99% min
  • Storage: Desiccate at +4°C
  • LimitNum: 100 Gram
  • Related Substances: /
  • Residue on Ignition: /
  • Heavy Metal: /
  • Valid Period: 2 years
  • Product name: Raloxifene
  • Molecular formula: C28H27NO4S
  • Molecular weight: 473.58
  • Melting point: 250-253°C

Superiority

Our advantage:
We have PEPTIDES and SARMS WAREHOUSE IN USA and Euro, you can receive order with 3 working days without any customs problems.
We offer drop ship to your end clients in worldwide.

 

Why Choose us:
1). We have our own GMP lab .
2). Warehouses in USA and Euro to support your urgent need.
3). We can customize Peptides and Test Report HPLC and MS are available.
4). / Bank Transfer / Credit Card /  Bitcoin / T/T in Advance / LC @ SIGHT / Paypal for your option.

 

Details

Product Description

 

Product name: Raloxifene

CAS No.: 84449-90-1

Molecular formula: C28H27NO4S

Molecular weight: 473.58

Melting point: 250-253°C

 

Raloxifene is mainly used to prevent and treat osteoporosis in postmenopausal women. It can significantly reduce the incidence of vertebral fractures, but the reduction in the incidence of hip fractures has not been confirmed. When deciding to choose raloxifene or other treatments (including estrogen) for postmenopausal women, it is necessary to consider the symptoms of menopause, the effect on the uterus and breast tissue, and the risk and beneficial effects on the cardiovascular system.

 

 

 

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog